Medicamen Biotech standalone net profit declines 27.43% in the June 2025 quarter
Sales decline 7.30% to Rs 38.45 crore
Net profit of Medicamen Biotech declined 27.43% to Rs 1.64 crore in the quarter ended June 2025 as against Rs 2.26 crore during the previous quarter ended June 2024. Sales declined 7.30% to Rs 38.45 crore in the quarter ended June 2025 as against Rs 41.48 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales38.4541.48 -7 OPM %10.4811.72 -PBDT3.944.76 -17 PBT2.173.02 -28 NP1.642.26 -27Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 12 2025 | 5:20 PM IST